Seymour Howard Fein - CRO/CMO at Oncotelic Therapeutics, Inc.

Issuer-level insider activity

Role
Cro/Cmo
Issuer ticker
OTLC on OTC
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Seymour Howard Fein since 02 Aug 2025

Reported holdings for Seymour Howard Fein in Oncotelic Therapeutics, Inc.

Form 4 holding CRO/CMO

Oncotelic Therapeutics, Inc.

Security class
Restricted stock Units
Shares / value
250
Estimated value
Report date
10 Jul 2026
Price
Ownership
Direct
Underlying class
Series A Preferred Stock
Underlying amount

Transaction history for Seymour Howard Fein in Oncotelic Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .